Web-based Genetic Research on Lupus
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Systemic Lupus Erythematosus
- Sponsor
- 23andMe, Inc.
- Enrollment
- 5000
- Locations
- 1
- Primary Endpoint
- Online survey
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
The goal of this new lupus research study is two-fold: first, to understand the genetic associations found between people's DNA and this disease, and second, to apply this understanding to drug development efforts with the investigator's partners at Pfizer.
Detailed Description
Lupus is a difficult disease to diagnose and one that's difficult to manage, given the lack of specific medicines to treat lupus and the side-effects of current medications. The investigators believe genetics may play a critical role in developing better lupus diagnoses and treatments. If individuals are eligible to participate, the investigators will send a 23andMe DNA saliva kit at no cost. Participants will be asked to take a 15 minute online survey with questions about their lupus experience, symptoms and response to treatments, in addition to five additional bi-monthly short surveys and one final study survey during the 12-month participation. Learn more and join the lupus study today: https://www.23andme.com/lupus/
Investigators
Eligibility Criteria
Inclusion Criteria
- •diagnosed with lupus by a qualified physician.
- •consents to have 23andMe (via a partner) contact the physician to obtain medical record information
- •willing to submit a saliva sample for DNA testing and complete online surveys related to condition
- •at least 6 years old (minors under 18 require parental consent to enroll)
- •access to the internet
- •resides in the United States
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Online survey
Time Frame: 12 months
Questions about lupus experience, symptoms and response to treatment
Salivary DNA sample for genetic analysis
Time Frame: 12 months